Google’s DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year.
2 Comments so far
Leave a Comment
If you are already a member, you can use this form to update your payment info.
Google’s DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year.
If you are already a member, you can use this form to update your payment info.
A breakthrough in applying AI to medicine.
If Isomorphic Labs’ AI-designed drugs make it to clinical trials this year, it could signal a shift in how pharmaceuticals are developed—potentially speeding up the process and reducing costs. However, the real test will be whether these AI-designed compounds prove safe and effective in humans. If successful, it could revolutionize medicine, but regulatory and ethical challenges will still need to be addressed.